From: S100β as a serum marker in endocrine resistant breast cancer
S100β ≥0.13 μg/Ln = 10 (8.47%) | S100β <0.13 μg/Ln = 108 (91.53%) | p value | |
---|---|---|---|
Age | |||
≥55 | 3 (30%) | 64 (59.26%) | 0.099 |
< 55 | 7 (70%) | 44 (40.74%) | |
PR | |||
+ ve | 8 (80%) | 87 (80.56%) | 1.00 |
–ve | 2 (20%) | 21 (19.44%) | |
HER2 | |||
+ ve | 3 (30%) | 52 (51.49%) | 0.097 |
–ve | 7 (70%) | 49 (48.51%) | |
Node | |||
+ ve | 2 (22.22%) | 43 (47.25%) | 0.162 |
–ve | 7 (77.78%) | 48 (52.75%) | |
Grade | |||
≥3 | 4 (40%) | 26 (24.07%) | 0.273 |
<3 | 6 (60%) | 82 (75.93%) | |
Size | |||
≥20 mm | 7 (100%) | 81 (96.43%) | 1.00 |
< 20 mm | – | 3 (3.57%) | |
Recurrence | |||
+ ve | 5 (50%) | 17 (15.74%) | 0.019 (r = +0.245) |
–ve | 5 (50%) | 91 (84.26%) |